CINECA IRIS Institutional Research Information System

CORSINI, GIOVANNI UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 17.541
NA - Nord America 17.141
AS - Asia 7.804
SA - Sud America 892
AF - Africa 253
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 43.651
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.399
FI - Finlandia 7.754
PL - Polonia 4.307
CA - Canada 2.643
CN - Cina 2.487
SG - Singapore 2.323
IT - Italia 1.480
SE - Svezia 1.005
HK - Hong Kong 931
GB - Regno Unito 773
BR - Brasile 736
KR - Corea 550
VN - Vietnam 531
BG - Bulgaria 495
UA - Ucraina 460
DE - Germania 427
TR - Turchia 346
FR - Francia 250
RU - Federazione Russa 236
CH - Svizzera 176
IN - India 160
JP - Giappone 107
BD - Bangladesh 96
CI - Costa d'Avorio 81
AR - Argentina 51
IQ - Iraq 44
MX - Messico 37
SA - Arabia Saudita 35
ZA - Sudafrica 34
BE - Belgio 32
VE - Venezuela 32
PK - Pakistan 26
SN - Senegal 26
NL - Olanda 25
EC - Ecuador 23
KE - Kenya 23
UZ - Uzbekistan 23
ES - Italia 22
MA - Marocco 19
TN - Tunisia 16
AT - Austria 15
IL - Israele 14
AE - Emirati Arabi Uniti 13
GR - Grecia 13
ID - Indonesia 13
JO - Giordania 13
JM - Giamaica 12
BB - Barbados 11
CO - Colombia 11
MY - Malesia 11
NG - Nigeria 11
CZ - Repubblica Ceca 10
IE - Irlanda 10
KZ - Kazakistan 10
PY - Paraguay 10
QA - Qatar 10
UY - Uruguay 10
TT - Trinidad e Tobago 9
AL - Albania 8
BJ - Benin 8
CR - Costa Rica 8
NP - Nepal 8
PE - Perù 8
AU - Australia 7
AZ - Azerbaigian 7
DZ - Algeria 7
EG - Egitto 7
NZ - Nuova Zelanda 7
OM - Oman 7
PH - Filippine 7
HU - Ungheria 6
LB - Libano 6
CL - Cile 5
EE - Estonia 5
ET - Etiopia 4
HN - Honduras 4
MD - Moldavia 4
PT - Portogallo 4
BO - Bolivia 3
BY - Bielorussia 3
EU - Europa 3
KG - Kirghizistan 3
LT - Lituania 3
LV - Lettonia 3
PS - Palestinian Territory 3
RO - Romania 3
SY - Repubblica araba siriana 3
AG - Antigua e Barbuda 2
AM - Armenia 2
BF - Burkina Faso 2
BS - Bahamas 2
BW - Botswana 2
BZ - Belize 2
GE - Georgia 2
GH - Ghana 2
HR - Croazia 2
JE - Jersey 2
LY - Libia 2
NI - Nicaragua 2
PA - Panama 2
Totale 43.607
Salva come PNG Salva come JPEG
Città #
Helsinki 7.480
Montreal 2.306
Ashburn 1.407
Woodbridge 1.390
Singapore 1.368
Fairfield 1.177
Ann Arbor 1.081
Houston 1.008
Chandler 947
Hong Kong 918
Hefei 746
Santa Clara 686
San Jose 676
Jacksonville 589
Milan 554
Seoul 540
Seattle 533
Dallas 494
Sofia 494
Cambridge 420
Wilmington 410
Beijing 407
Lancaster 391
Shanghai 369
New York 304
Ottawa 286
Izmir 227
Los Angeles 217
Boardman 206
Nanjing 196
Princeton 193
Lawrence 187
Medford 172
Lauterbourg 170
Bern 157
Serra 132
Des Moines 131
Dearborn 128
Buffalo 125
Jüchen 100
Ho Chi Minh City 99
Tokyo 99
London 96
Istanbul 93
Nanchang 93
Dong Ket 88
Abidjan 81
Hanoi 78
Chicago 77
São Paulo 68
San Diego 56
Redondo Beach 47
Kunming 45
Ogden 45
Redwood City 45
Rome 45
Frankfurt am Main 42
Boulder 40
Council Bluffs 40
Columbus 35
Munich 35
Brussels 32
The Dalles 32
Norwalk 30
Florence 29
Pune 29
Shenyang 27
Bremen 26
Changsha 26
Dakar 26
Düsseldorf 26
Rio de Janeiro 26
Hebei 25
Tianjin 23
Falls Church 22
Tashkent 22
Dhaka 21
Nairobi 21
Verona 21
Phoenix 19
Da Nang 18
Guangzhou 18
Jiaxing 18
Orange 18
Turku 18
Zurich 17
Orem 16
Riyadh 16
Belo Horizonte 15
Baghdad 14
Paris 14
Washington 14
Amman 13
Fuzhou 13
Grafing 13
Haiphong 13
Johannesburg 13
Mumbai 13
Pisa 12
Auburn Hills 11
Totale 31.449
Salva come PNG Salva come JPEG
Nome #
Parkinsonism by MPTP in mice: a model for regenerative processes of nigrostriatal dopaminergic pathway 5.314
MPTP FAILS TO INDUCE LIPID-PEROXIDATION INVIVO 3.950
PARKINSONS-DISEASE AND PESTICIDES 3.049
HIGH-AFFINITY BINDING-SITES FOR 1-METHYL-4-PHENYL-PYRIDINIUM ION (MPP+) ARE PRESENT IN MOUSE-BRAIN 2.395
[H-3] 1-METHYL-4-PHENYL-2,3-DIHYDROPYRIDINIUM ION BINDING-SITES IN MOUSE-BRAIN - PHARMACOLOGICAL AND BIOLOGICAL CHARACTERIZATION 253
G protein-linked receptors: pharmacological evidence for the formation of heterodimers 248
Pharmacological manipulation of embryonic dopaminergic neurons implanted in adult mouse striatum: a new therapeutical approach to Parkinson’s disease. 245
Characterization of the Engrailed mutant mice as experimental models for Parkinson's disease 245
Partial agonist actions at dopamine D2L receptors are modified by co-transfection of D3 receptors: potential role of heterodimer formation 236
Embryonic neural grafts induce recovery in mice with permanent striatal lesion 229
Localization of a glutathione-dependent dehydroascorbate reductase within the central nervous system of the rat 229
D-1 AND D-2 DOPAMINE SYSTEM INTERACTIONS IN THE MPTP-LESIONED MONKEY 225
Ethanol intake and ethanol-induced locomotion and locomotor sensitization in CYP2E1 knockout mice 225
(+)MK-801 PREVENTS THE DDC-INDUCED ENHANCEMENT OF MPTP TOXICITY IN MICE 225
Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology. 223
Fluorescent light induces neurodegeneration in the rodent nigrostriatal system but near infrared LED light does not 222
Cytochrome P450 and Parkinson's disease: protective role of neuronal CYP 2E1 from MPTP toxicity 215
Pharmacological modulation of regenerative processes aftar nigrostriatal dopaminergic lesion: a new therapeutical approach to Parkinson’s disease 211
Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT2A receptor agonism 210
Region- and neurotransmitter-dependent species and strain differences in DSP-4-induced monoamine depletion in rodents. 209
INCREASED PAROXYSMAL ACTIVITY OF PARTIAL SEIZURES IN MAN BY APOMORPHINE 208
Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease 208
Assessing neuroprotection in Parkinson's disease: from the animal models to molecular neuroimaging in vivo 207
Apomorphine offers new insight into dopaminergic neuron vulnerability in mesencephalic cultures 207
PHARMACOLOGICAL MANIPULATION OF EMBRYONIC DOPAMINERGIC-NEURONS IMPLANTED IN ADULT-MOUSE STRIATUM - A NEW THERAPEUTIC APPROACH TO PARKINSONS-DISEASE 204
1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE - CORRESPONDENCE OF ITS BINDING-SITES TO MONOAMINE-OXIDASE IN RAT-BRAIN, AND INHIBITION OF DOPAMINE OXIDATIVE DEAMINATION INVIVO AND INVITRO 203
HIGH-AFFINITY BINDING OF [H-1]1-METHYL-4-PHENYL-2,3-DIHYDROPYRIDINIUM ION TO MOUSE STRIATAL MEMBRANES - PUTATIVE VESICULAR LOCATION 203
Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation 203
Revealing G-protein-coupled receptor oligomerization at the single-molecule level through a nanoscopic lens: Methods, dynamics and biological function 202
EVIDENCE FOR DOPAMINE RECEPTORS IN HUMAN-BRAIN MEDIATING SEDATION AND SLEEP 201
Clonidine prevents while yohimbine enhances MPTP toxicity in mice. 201
Serotonin abnormalities in engrailed-2 knockout mice: new insight relevant for a model of autism spectrum disorder 201
COVALENT BINDING AS A BIOCHEMICAL MECHANISM FOR TOXICITIES COVALENT BINDING OF STILBENE (ST) AND DIETHYLSTILBESTROL (DES) TO LIVER-MICROSOMES 200
DEPRENYL SELECTIVELY INHIBITS [H-3] MPTP BINDING-SITES IN MONKEY BRAIN 199
Acetaldehyde and parkinsonism: role of CYP450 2E1. 199
TSH-Dependent Expression of the LDL Receptor-Associated Protein (RAP) in Thyroid Epithelial Cells 197
MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice 197
Pharmacologic modulation of MPTP toxicity: MK 801 in prevention of dopaminergic cell death in monkeys and mice. 195
Role of CYP2E1 in the mouse model of MPTP toxicity 194
Behavioral, Neurochemical, and Electrophysiological Changes in an Early Spontaneous Mouse Model of Nigrostriatal Degeneration 194
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences 194
EFFECTS OF BIGUANIDES ON FATTY-ACID AND GLUCOSE OXIDATION IN MUSCLE 193
MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates. 193
INHIBITION OF [H-3] MPTP BINDING TO RAT-BRAIN BY PARGYLINE 192
APOMORPHINE HYDROCHLORIDE-INDUCED IMPROVEMENT IN HUNTINGTONS-CHOREA - STIMULATION OF DOPAMINE RECEPTOR 191
SELECTIVE INCREASE OF BRAIN DOPAMINE SYNTHESIS BY SULPIRIDE 187
MPTP TREATMENT COMBINED WITH ETHANOL OR ACETALDEHYDE SELECTIVELY DESTROYS DOPAMINERGIC-NEURONS IN MOUSE SUBSTANTIA NIGRA 187
CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicity 187
Identification and determination of 3,4-dihydroxyphenylacetaldehyde, the dopamine metabolite in in vivo dialysate from rat striatum. 185
DECREASED CONVERSION OF TYROSINE TO CATECHOLAMINES IN BRAIN OF RATS TREATED WITH PARA CHLOROPHENYLALANINE 184
Increased susceptibility to kainic acid-induced seizures in Engrailed-2 knockout mice. 184
Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors. 184
Sodium nitroprusside induces internalization of muscarinic receptors stably expressed in Chinese hamster ovary cell lines 183
Effects of Pretreatment with N-(2-Chloroethyl)-N- Ethyl-2-Bromobenzylamine (DSP-4) of Methamphetamine Pharmacokinetics and Striatal Dopamine losses 183
Modulation of dihydroxyphenylacetaldehyde extracellular levels in vivo in the rat striatum after different kinds of pharmacological treatment 180
THERAPEUTIC EFFICACY OF APOMORPHINE COMBINED WITH AN EXTRA-CEREBRAL INHIBITOR OF DOPAMINE RECEPTORS IN PARKINSONS-DISEASE 179
Functional role of the third cytoplasmic loop in muscarinic receptor dimerization. 179
METOCLOPRAMIDE AND DYSTONIC REACTIONS IN SARDINIANS 179
From dopamine metabolism to Parkinson’s disease. 179
Effect of metadoxine on striatal dopamine levels in C57 black mice 179
Pharmacological modulation of regenerative processes after nigrostriatal dopaminergic lesion: A new therapeutical approach to Parkinson's disease 179
Apomorphine has a potent antiproliferative effect on Chinese hamster ovary cells 179
DOMPERIDONE AND APOMORPHINE IN HUNTINGTONS-CHOREA 178
EFFECT OF ORAL-ADMINISTRATION OF TRYPTOPHAN-FREE AMINO-ACID MIXTURES ON SERUM TRYPTOPHAN, BRAIN TRYPTOPHAN AND SEROTONIN METABOLISM 177
PROPERTIES OF BENZODIAZEPINE BINDING-SITES IN PERIPHERAL-TISSUES 177
DOPAMINERGIC MECHANISMS IN HEMIPARKINSONIAN MONKEYS 176
ACETALDEHYDE DIRECTLY ENHANCES MPP+ NEUROTOXICITY AND DELAYS ITS ELIMINATION FROM THE STRIATUM 176
SPECIFIC REINNERVATION OF LESIONED MOUSE STRIATUM BY GRAFTED MESENCEPHALIC DOPAMINERGIC-NEURONS 176
Dopamine agonists and analogues have an antiproliferative effect on CHO-K1 cells 176
Long-term treatment of bipolar disorder:how should we use lithium salts? 176
EFFECT OF APOMORPHINE ON HUMAN SLEEP 175
MODULATION OF DOPAMINE AGONIST ACTION BY ESTROGENS 173
INHIBITION OF NITRIC-OXIDE SYNTHASE DRAMATICALLY POTENTIATES SEIZURES INDUCED BY KAINIC ACID AND PILOCARPINE IN RATS 173
DOPAMINE AGONISTS IN THE TREATMENT OF SCHIZOPHRENIA 170
Biochemestry of experimental parkinsonism. 170
PARKINSONISM BY HALOPERIDOL AND PIRIBEDIL 168
Nicotine prevents experimental parkinsonism in rodents. 168
An unusual form of the association binding kinetics of N-[ [H-3] methylscopolamine to the split muscarinic M-2trunk/M-2tail receptor 167
PHARMACOLOGICAL MODULATION OF DEVELOPMENT AND PLASTICITY IN NIGRO-STRIATAL DOPAMINERGIC-NEURONS 167
Norepinephrine loss selectively enhances chronic nigrostriatal dopamine depletion in mice and rats 166
CHARACTERIZATION OF A PUTATIVELY VESICULAR BINDING-SITE FOR [H-3] MPP+ IN MOUSE STRIATAL MEMBRANES 165
Mk-801 previene la degenerazione dei neuroni dopaminergici nigrostriatali indotta da MPTP: ruolo degli aminoacidi eccitatori nei processi di invecchiamento del sistema nigrostriatale. 164
Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism. 164
Is lithium able to reverse neurological damage induced by vinca alkaloids? 163
Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice 163
Dose-dependent induction of apoptosis by R-apomorphine in CHO-K 1 cell line in culture 163
Molecular and cellular events regulating dopamine survival 162
Cytochrome p450 and parkinsonism: protective role of CYP2E1 162
ROLE OF H-3 MPP+ BINDING-SITES IN THE MPTP NEUROTOXICITY USING QUANTITATIVE AUTORADIOGRAPHY 161
Antagonist binding profile of the split chimeric muscarinic m2-trunc/m3-tail receptor 161
Involvment of excitatory aminoacids in MPTP toxicity 160
IN BROWN-NORWAY RATS, MPP(+) IS ACCUMULATED IN THE NIGROSTRIATAL DOPAMINERGIC TERMINALS BUT IT IS NOT NEUROTOXIC - A MODEL OF NATURAL-RESISTANCE TO MPTP TOXICITY 160
TRYPTOPHAN-FREE DIETS - NEW MEANS FOR EFFECTIVELY DECREASING BRAIN-SEROTONIN SYNTHESIS IN ANIMALS AND MAN 159
Noradrenergic modulation of methamphetamine-induced striatal dopamine depletion 159
Species differences in the role of excitatory amino acids in experimental parkinsonism. 157
MK801 prevents MPTP-induced dopaminergic cell death in monkeys and mice 155
Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice. 155
Effects of locus coeruleus lesions on development of functional propertues of rat visual cortical neurons. 154
(+) MK-801 PREVENTS DIETHYLDITHIOCARBAMATE-INDUCED NEURONAL DAMAGE 153
EVALUATION OF THE TOXICITY OF THE DOPAMINERGIC NEUROTOXINS MPTP AND MPP+ IN PC12 PHEOCHROMOCYTOMA CELLS - BINDING AND BIOLOGICAL STUDIES 152
Totale 32.742
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.129
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021366 0 0 0 0 0 0 0 0 0 0 102 264
2021/20222.059 66 106 41 155 413 269 32 96 102 73 86 620
2022/20232.469 355 354 124 241 274 359 27 184 389 12 125 25
2023/20248.729 386 212 335 124 267 369 42 74 42 6.644 43 191
2024/20256.298 32 207 37 353 534 507 403 280 498 727 823 1.897
2025/202612.950 423 1.037 825 363 384 623 1.026 222 7.613 364 70 0
Totale 43.883